Podcasts about duke university school

One in four adults has some form of arthritis, and osteoporosis-related fractures affect one in two women over fifty. Yet very few resources bring together the full picture of how to prevent and treat these conditions through everyday choices. Our guest is Dr. Jocelyn Wittstein, a board-certified orthopedic surgeon and associate professor of orthopedic surgery at Duke University School of Medicine, specializing in sports medicine and co-author of THE COMPLETE BONE AND JOINT HEALTH PLAN: Help Prevent and Treat Osteoporosis and Arthritis.

In this episode, Tracey L. Yap, RN, PhD, Professor at the Duke University School of Nursing and Senior Fellow in the Duke University Center for the Study of Aging and Human Development, discusses how to justify the cost of a pressure injury prevention program to your CFO. She shares insights on prevention's economic value, cultural buy-in, and practical strategies for implementation. This episode is sponsored by Smith+Nephew. 

The US leads the world in biomedical innovation, with about 40% of patents being filed by US scientists and companies. The FDA plays a critical role in supporting and enabling this innovation pipeline and our guest Dr. Robert Califf was commissioner of the agency not once, but twice under Presidents Obama and Biden. He joins us to talk about what Americans should know about FDA's critical role and the threats to its functioning from the dramatic cuts the Trump administration has made over the last three months.We discuss:The broad sweep of FDA's purview from drugs and medical devices to cosmetics, food, tobacco and dog foodConcern that the FDA is now “decapitated and eviscerated” from the massive and multiple rounds of dismissalsWhile most industries want less regulation, the pharma industry wants more information and guidance from the FDACaliff has been affiliated with Duke for 50 of its 100 years, but a part of his heart is still with ClemsonWhat would Califf's “Make America Healthy Again” agenda be?“We need to develop reliable, repetitive sources of information that help people do things that are healthy and beneficial. That part of MAHA I like a lot…The second thing is… I'm developing connections with people who are thinking differently about primary care because I think everybody agrees there's no way you can take the current workforce and deliver what's needed. So it's got to be linked up with AI and digital technologies, but also with a very different looking workforce that gets paid differently, has more respect.”Relevant LinksRead Califf's WSJ opinion letter: “Work with the Bureaucracy, Not Against It”Peter Marks' resignation letter NYT article on the impact of FDA layoffsCaliff's “Public Health on Call” podcast episode on the state of the FDA Opinion article from 7 previous FDA commissioners on how recent changes are undermining credibility of the FDAAbout Our GuestRobert M. Califf, MD served as FDA Commmissioner under Presidents Biden and Obama. Califf is a nationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, and a leader in the growing field of translational research. Prior to rejoining the FDA in 2022, Califf was head of medical strategy and senior advisor at Alphabet, contributing to strategy and policy for its health subsidiaries Verily Life Sciences and Google Health. Prior to Alphabet, he was professor of medicine and vice chancellor for clinical and translational research at Duke University, director of the Duke Translational Medicine Institute, and founding director of the Duke Clinical Research Institute. Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.Connect With UsFor more information on...

Dr. Sandra Hassink is joined by Dr. Asheley C. Skinner, Professor of Population Health at Duke University School of Medicine. Dr. Skinner also served as the methodologist on the Clinical Practice Guideline (CPG) for the Evaluation and Treatment of Children and Adolescents with Obesity. Together, they discuss the evidence behind the CPG. Related Resources: • Obesity CPG Homepage (tinyurl.com/52nz6m2m) • CPG Technical Report (I) (https://tinyurl.com/y7bnnsmc) • CPG Technical Report (II) (https://tinyurl.com/mv3s6eau)

This episode of Don't Miss a Beat centers on the evolving treatment landscape for transthyretin amyloid cardiomyopathy (ATTR-CM) with special guest Ahmad Masri, MD. Hosts Muthiah Vaduganathan, MD, MPH, a cardiologist and codirector of the Center for Cardiometabolic Implementation Science at Brigham and Women's Hospital, and Steve Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, are joined by Masri, who serves as the director of the HCM and Amyloid Program at Oregon Health & Science University, to discuss the rapid therapeutic advances in ATTR-CM and the emerging questions shaping real-world clinical practice. Masri reviews the progression from a previously untreatable disease to one now managed with three US Food and Drug Administration (FDA)-approved disease-modifying agents: tafamidis (VYNDAMAX), acoramidis (Attruby), and vutrisiran (AMVUTTRA). He highlights the tafamidis approval in 2019 as a landmark in the field, showing a substantial survival benefit in the ATTR-ACT trial, followed by similar results from acoramidis, which received approval in late 2024, in ATTRibute-CM. Vutrisiran, a TTR gene silencer approved by the FDA in March 2025, represents a mechanistically distinct approach validated in the HELIOS-B trial. Despite these advances, Masri notes that patients with late-stage disease derive limited symptomatic benefit and that residual risk remains high, even with treatment. The conversation explores whether stabilizers and silencers can or should be combined, with Masri urging caution, citing the absence of clinical data demonstrating additive benefit and warning against assumptions of harmony without clinical evidence. Masri indicated ongoing trials, such as CARDIO-TTRansform, may offer clarity on this issue. Without direct comparisons between therapies, treatment selection often hinges on patient preference, delivery method, pill burden, and payer coverage. In practice, clinicians rely on pharmacodynamic markers, like changes in TTR levels, to assess treatment effect and adjust therapy accordingly. Masri emphasizes that while ATTR-CM trials may not show improvements in quality-of-life scores, slowing disease progression remains a critical and meaningful endpoint in this severe, high-mortality condition. Looking ahead, the panel discusses the next wave of therapeutic innovation. Multiple trials are now testing agents that aim to clear amyloid from the myocardium, including NI006 (ALXN2220), PRX004, and AT-02. These immune-modulating treatments are designed for long-term use and may complement stabilizers or silencers in patients with established amyloid burden. The episode closes with a discussion on prevention. For patients with asymptomatic cardiac involvement, current therapies halt disease progression entirely in many cases. For those with pathogenic TTR variants but no overt disease, surveillance is the current standard. However, Masri introduces the ACT Early trial, which will test whether early treatment with acoramidis can prevent the onset of clinical disease in high-risk individuals, potentially reshaping the paradigm of ATTR-CM care. Relevant disclosures for Vaduganathan include Amgen, AstraZeneca, Bayer AG, Boehringer Ingelheim Pharmaceuticals, Cytokinetics, Lexicon, and others. Relevant disclosures for Greene include Amgen, AstraZeneca, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Cytokinetics, and others. Key Episode Timestamps 00:00:00 Introduction and Guest Introduction 00:00:52 Current State of Amyloid Therapeutics 00:03:41 Introduction of New Stabilizers and Silencers 00:06:05 Combination Therapy and Clinical Data 00:10:36 Choosing Therapy for Patients 00:16:40 Disease Progression and Clinical Trials 00:20:28 Pipeline and Future Therapies 00:23:51 Preventative Therapy and Asymptomatic Patients 00:27:19 Conclusion and Future Directions

We kicked off the program with four news stories and different guests on the stories we think you need to know about!May is National Arthritis Awareness Month AND National Osteoporosis Awareness and Prevention Month.  Anyone over age 50 has an increased risk for arthritis AND osteoporosis! How to help & treat arthritis and osteoporosis with guest Dr. Jocelyn Wittstein - board-certified orthopedic surgeon and associate professor of orthopedic surgery at Duke University School of Medicine.Highlighting females in Corrections & Tackling Safety on Cape Cod this Summer with guest Sheriff Donna Buckley – Sheriff of Barnstable County.The Celtics-Knicks Series with guest Bob Ryan - Boston Globe Sports Columnist.Local Boston man involved in the national drug trafficking ring and the huge fentanyl busts reminds us just how close this crisis hits to home. A real story of what's broken and how we fix it… Why summer months see the lowest engagement in treatment and recovery with guest  Adam Vibe Gunton - national leader in the recovery movement.Listen to WBZ NewsRadio on the NEW iHeart Radio app and be sure to set WBZ NewsRadio as your #1 preset!

Schenita D. Randolph. Dr. Schenita D. Randolph is an Associate Professor at Duke University School of Nursing and Founding Director of the HEEAT Lab, which stands for addressing Health disparities through Engagement, Equity, Advocacy and Trust. A registered nurse for over 25 years, Dr. Randolph is advancing nursing science by using community partnerships to address the health inequities among Black Families living in the United States south. Her work has received national attention in the popular media and has been supported by public and private funders. She has publications in numerous journals including the New England Journal of Medicine and the Journal of the American Medical Association, that highlight population health and community engagement in education and research. She is a Fellow in the American Academy of Nursing which represent nursing’s most accomplished leaders in policy, research, administration, practice, and academia. She is a proud HBCU graduate of North Carolina Agricultural and Technical (A&T) State University. Dr. Randolph is dedicated to partnering with the community to develop culturally and socially relevant interventions that will advance health equity and improve health outcomes for minoritized communities. She is also committed to mentoring and supporting the next generation of nurse leaders and scientists. Company Description * The HEEAT Lab is an interdisciplinary team of researchers, clinicians, business owners, and community members who are dedicated to addressing health disparities through equity, engagement, advocacy, and trust. #BEST #STRAW #SHMSSupport the show: https://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Schenita D. Randolph. Dr. Schenita D. Randolph is an Associate Professor at Duke University School of Nursing and Founding Director of the HEEAT Lab, which stands for addressing Health disparities through Engagement, Equity, Advocacy and Trust. A registered nurse for over 25 years, Dr. Randolph is advancing nursing science by using community partnerships to address the health inequities among Black Families living in the United States south. Her work has received national attention in the popular media and has been supported by public and private funders. She has publications in numerous journals including the New England Journal of Medicine and the Journal of the American Medical Association, that highlight population health and community engagement in education and research. She is a Fellow in the American Academy of Nursing which represent nursing’s most accomplished leaders in policy, research, administration, practice, and academia. She is a proud HBCU graduate of North Carolina Agricultural and Technical (A&T) State University. Dr. Randolph is dedicated to partnering with the community to develop culturally and socially relevant interventions that will advance health equity and improve health outcomes for minoritized communities. She is also committed to mentoring and supporting the next generation of nurse leaders and scientists. Company Description * The HEEAT Lab is an interdisciplinary team of researchers, clinicians, business owners, and community members who are dedicated to addressing health disparities through equity, engagement, advocacy, and trust. #BEST #STRAW #SHMSSee omnystudio.com/listener for privacy information.

Schenita D. Randolph. Dr. Schenita D. Randolph is an Associate Professor at Duke University School of Nursing and Founding Director of the HEEAT Lab, which stands for addressing Health disparities through Engagement, Equity, Advocacy and Trust. A registered nurse for over 25 years, Dr. Randolph is advancing nursing science by using community partnerships to address the health inequities among Black Families living in the United States south. Her work has received national attention in the popular media and has been supported by public and private funders. She has publications in numerous journals including the New England Journal of Medicine and the Journal of the American Medical Association, that highlight population health and community engagement in education and research. She is a Fellow in the American Academy of Nursing which represent nursing’s most accomplished leaders in policy, research, administration, practice, and academia. She is a proud HBCU graduate of North Carolina Agricultural and Technical (A&T) State University. Dr. Randolph is dedicated to partnering with the community to develop culturally and socially relevant interventions that will advance health equity and improve health outcomes for minoritized communities. She is also committed to mentoring and supporting the next generation of nurse leaders and scientists. Company Description * The HEEAT Lab is an interdisciplinary team of researchers, clinicians, business owners, and community members who are dedicated to addressing health disparities through equity, engagement, advocacy, and trust. #BEST #STRAW #SHMSSteve Harvey Morning Show Online: http://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Episode Topic: Generosity & Medicine with physicians Sneha Mantri, MD, MS and Abraham Nussbaum, MD As part of the Virtues & Vocations series Education for Flourishing: Conversations on Character & the Common Good, we are pleased to welcome Sneha Mantri, MD, MS, physician and director of Medical Humanities at Duke University School of Medicine, and Abraham Nussbaum, MD, physician, Chief Education Officer at Denver Health, and an author of several books, including the recently released Progress Notes. Mantri and Nussbaum wrote essays on generosity for the fall issue of the Virtues & Vocations magazine. Listen in on a discussion of their essays and others from the issue, American healthcare, and medical education.Featured Speakers:Suzanne Shanahan, Leo and Arlene Hawk Executive Director and Professor of the Practice at Notre Dame's Center for Social ConcernsSneha Mantri, MD, MS, physician and director of Medical Humanities at Duke University School of Medicine,Abraham Nussbaum, MD, physician, Chief Education Officer at Denver HealthRead this episode's recap over on the University of Notre Dame's open online learning community platform, ThinkND: https://go.nd.edu/92fe62.This podcast is a part of the ThinkND Series titled Virtues & Vocations. Thanks for listening! The ThinkND Podcast is brought to you by ThinkND, the University of Notre Dame's online learning community. We connect you with videos, podcasts, articles, courses, and other resources to inspire minds and spark conversations on topics that matter to you — everything from faith and politics, to science, technology, and your career. Learn more about ThinkND and register for upcoming live events at think.nd.edu. Join our LinkedIn community for updates, episode clips, and more.

What if AI could guide every patient through their healthcare journey—nudging them toward better choices, anticipating their needs, and adapting in real time? We talk a lot about engagement in healthcare, but too often, the digital tools we use fail to improve outcomes. AI and data-driven personalization hold incredible promise, yet many health plans and providers still struggle with low participation rates. Dr. Erich Huang, Associate Chief Clinical Officer for Informatics and Technology at Verily, an Alphabet company leading the charge in precision health, joins Eric to discuss what's next for AI in healthcare. The conversation touches on how AI is redefining patient engagement, the delicate balance between automation and human touch, and how platforms like Verily's Lightpath are pioneering a new model for chronic care management. If you're a health plan or hospital leader looking to unlock the next generation of patient engagement, you won't want to miss this conversation.  About Erich Erich leads a team focused on structuring clinical-grade data that integrates with the clinical research and healthcare data ecosystems and is optimized for precision medicine, analysis, and artificial intelligence.    Erich was previously at Duke University where he served as the Chief Data Officer for Quality at Duke Health, Director of Duke Forge, Director of Duke Crucible, and Assistant Dean for Biomedical Informatics for Duke University School of Medicine. There, he led and deployed machine learning capabilities for complex care management in Duke Health's Accountable Care Organization, led health data science initiatives, and helped develop Duke Health's new institutional governance process for algorithmic decision support.    He earned his MD and PhD from Duke University, trained and was a Chief Resident in the Duke General Surgery Residency Program. Erich is previously a Burroughs Wellcome Fund Innovations in Regulatory Science Award recipient, received a Sidney Kimmel Cancer Research Foundation Translational Scholar Award, and is twice a recipient of an IBM Faculty Award.   About Verily Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable.  

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Tonia Poteat, a professor in the Duke University School of Nursing and co-director of the Duke SGM Wellness Program. Dr Poteat joins Dr Saag to provide an overview of a Themed Discussion session that she is leading at CROI 2025 entitled Meeting the Treatment and Prevention Needs of Transgender Women. Dr Poteat and Dr Saag address the 3 most common challenges faced in the care of transgender persons: uninformed clinicians, societal discrimination, and efforts by governments to limit the rights of transgender persons. They discuss efforts to educate clinicians and summarize the resources that are available to provide care to transgender persons facing stigma and discrimination. They also discuss efforts to take legal action against discriminatory policies. Finally, Dr Poteat and Dr Saag look ahead to the next five years of transgender care and provide advice to all involved in the care of transgender persons during a challenging time. 0:00 – Introduction1:26 – Overview of Dr Poteat's background and research interests3:42 – Most common challenges encountered by transgender women4:59 – Educating clinicians about care for transgender women9:46 – Resources for clinicians to learn about managing stigma and discrimination11:24 – Efforts by governments to limit transgender care16:14 – Overview of the Themed Discussion session at CROI 202519:07 – Looking ahead to the next five years in transgender careResources: CROI 2025: https://www.croiconference.org/IAS-USA webinar: Gender-Affirming Hormone Care for People With HIV: https://www.iasusa.org/events/webinar-2024-poteat/AIDS Education and Training Center: https://aidsetc.org/  World Professional Association for Transgender Health: https://wpath.org/  Trans Lifeline: https://translifeline.org/ Trevor Project: https://www.thetrevorproject.org/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

This week on Health Matters, as we continue to observe Heart Month, we will explore the role that genetics play in heart health.Understanding your family history of cardiovascular health is essential. In fact, about 30% of heart disease can be linked to family history. We speak with Dr. Jessica Hennessy, a clinical cardiac electrophysiologist and cardiogenetics expert at NewYork-Presbyterian and Columbia to help break down which heart conditions and risk factors may be inherited. She provides valuable insight on effectively managing heart health, including the importance of lifestyle modifications in preventing heart disease, including for individuals with a genetic predisposition. She also explains who should get genetic testing and what that process looks like.___ Dr. Jessica Hennessey specializes in Cardiac Electrophysiology, with a special focus on Sports & Exercise Cardiology. She practices primarily in New York, NY, and is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Hennessey graduated from Duke University School of Medicine in 2014, and completed her training at Massachusetts General Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Columbia University Irving Medical Center. She is board certified in Internal Medicine, Cardiovascular Disease and Cardiac Electrophysiology. ___ Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday. If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

The year is 2022. Simran Sethi Khanna just won ICPSR's Undergraduate Paper Competition for her work, "Determining LGB Perceptions of and Trust in the Medical Establishment," and joined Data Brunch to talk about her findings, her inspiration, and her love of Thai food. The year is 2025. Simran is now an MD candidate at the Duke University School of Medicine. She still loves Thai food.

Dr. Stephan Van Vliet joins us for an enlightening exploration of nutrition, agriculture, and human health. Our discussion navigates the often-overlooked complexities of food production, examining the nutritional differences between pasture-finished and grain-finished beef. We also uncover how maternal nutrition might set the stage for children's future dietary preferences. Dr. Van Vliet introduces the intriguing concept of the food matrix, emphasizing the profound impact of bioactive compounds in whole foods that go far beyond mere macronutrient content.As we venture into the emerging field of food metabolomics, Dr. Van Vliet reveals how metabolites in plants and animals can offer new insights into health optimization. The conversation highlights the critical role of dietary choices, particularly regarding the impact of diet on metabolite composition and the potential health benefits of shifting toward whole foods. Balancing plant-based and animal-derived diets also emerges as a focal point, underscoring the health potential of integrating both for optimal nutrient intake. Key Topics: The food matrix and why whole foods matter beyond macros Food metabolomics and the impact of diet on metabolite composition Nutritional differences between pasture-finished and grain-finished beef How maternal nutrition influences children's future health and food choices Why an omnivorous diet emerges as optimal for human healthWho is Dr. Stephan Van Vliet? Dr. Stephan Van Vliet is the Director at the Center for Human Nutrition Studies at Utah State University. Dr. Stephan Van Vliet earned his PhD in Kinesiology as an ESPEN Fellow from the University of Illinois at Urbana-Champaign, and received postdoctoral training at the Washington University in St Louis School of Medicine and Duke University School of Medicine prior to joining Utah State University in 2022.This episode is brought to you by: Timeline - Code DRLYON for 10% OFF - https://timelinenutrition.com/DRLYONCozy Earth - Code DRLYON for 40% OFF - https://cozyearth.com/DRLYONManukora - Code DRLYON for $25OFF Starter Kit! - https://manukora.com/DRLYONPuori - Code DRLYON for 20% OFF - https://puori.com/DRLYONFind Dr. Stephan Van Vliet at:The Van Vliet Lab - https://stephanvanvliet.com/X - https://x.com/vanvlietphd Find me at: Instagram: @drgabriellelyonTik Tok: @drgabriellelyonFacebook: facebook.com/doctorgabriellelyonYouTube: youtube.com/@DrGabrielleLyonJumpstart your 2025 with Dr. Gabrielle Lyon's 4-week Foundations Challenge —join now: https://bit.ly/3Wnd6KTApply to become a patient - https://drgabriellelyon.com/new-patient-inquiry/Join my weekly newsletter - https://institute-for-muscle-centric-medicine.ck.pageGet my book - https://drgabriellelyon.com/forever-strong/Timestamps: (00:00) - Understanding the Food Matrix(17:02) - Exploring Food Metabolomics and Nutrient Optimization(24:51) - Exploring Plant-Based and Animal-Derived...

Send us a textCan a Cancer cure overcome evolutionary pressures?  Human evolution is possible because of the extreme tendency for DNA to mutate.  This same tendency is what leads to mutations that cause cancer.  This episode takes an in depth look at cancer care from the point of view of two oncologist.  Dr. Robert Wehbie  and Dr. Roger Anderson.  You will hear them discuss how human evolution and cancer are inextricably bound together.We will explore the many types of cancersThe current state of clinical careLearn how cancer has evolved over the millenniaAnd whether or not a cure is finally on the horizon Dr. Wehbie is a chemotherapy oncologist in Raleigh, North Carolina.  He received his medical degree from the University of Wisconsin School of Medicine and Public Health and has bee in practice for more than 20 years.  He has expertise in treating lymphoma, lung cancer, prostate cancer, among other conditions.Dr. Roger Anderson is a radiation oncologist also in Raleigh, North Carolina.  He received his medical degree from Duke University School of Medicine and has been in practice for more than 40. Years.  As a radiation oncologist, Dr. Anderson treats a variety of cancers that we will more about during the podcast.https:/natureandsciencepodcast.com

From Dr. Chisaraokwu's website: "My art is a practice of retrieval, reanimation, and re-presentation of the parts of ourselves lost in the wake of trauma. Poetry is the sound, the feel, of those missing | mis-seen parts— raw, unapologetic, found, free. .CHISARAOKWU. is an Igbo American transdisciplinary poet artist, scholar, writer, performer, health futurist, and a 2023 California Arts Council Fellow. Inspired by her love of history, dreamscapes, the environment, quantum physics, and all things Africa(n)|(in)diaspora, she weaves images, textures, and text to create poems. Her work has been honored with awards and fellowships from MacDowell, Cave Canem, Vermont Studio Center, Anaphora Arts, Ucross and Headlands Center for the Arts, among other honors. She is an alum of the Brooklyn Poets Mentorship Program and the 2022 Tin House Winter Workshop. Nominated for Best of Net (Poetry; 2019, 2020, 2021), Best New Poets (2022), and Best New Small Fiction (2022), her words have appeared in academic and literary journals including Transition, Obsidian, midnight&indigo, The Lancet, and The New England Journal of Medicine. Her debut visual art work is featured in Michigan Quarterly Review's Spring 2024 issue, African Cartographies edited by Chris Abani. She earned her BA in History from Stanford University, MD from Duke University School of Medicine, MSPH from UNC Gilling School of Global Public Health, and certification in Global Mental Health & Trauma from Harvard School of Public Health's Refugee Trauma Program. She is a retired pediatrician and an alum of the Robert Wood Johnson Foundation Clinical Scholars Program at Yale University where her research focused on adverse childhood experiences, mental health and spirituality, and community-based participatory research projects. She is currently working on two poetry collections and a novel. She is the recipient of the National Endowment for the Arts Creative Writing Fellowship for 2025!! https://www.arts.gov/.../creative.../chisaraokwu-asomugha

To our podcasting community – from creators to advertisers and beyond: Our thoughts are with you as Southern California grapples with these devastating wildfires. We're here for you, and we're committed to supporting one another through this challenging time. Stay safe. What a way to start 2025. In addition to discussing the devastation of the wildfires in L.A. we share updates on public domain content for 2025, the Zoom H1 XLR, The Shure MV7i, advice for starting a podcast in 2025, the overwhelming popularity of true crime podcasts, exploring audience insights and trends, and of course stats! Mean and median numbers!

To our podcasting community – from creators to advertisers and beyond: Our thoughts are with you as Southern California grapples with these devastating wildfires. We're here for you, and we're committed to supporting one another through this challenging time. Stay safe. What a way to start 2025. In addition to discussing the devastation of the wildfires in L.A. we share updates on public domain content for 2025, the Zoom H1 XLR, The Shure MV7i, advice for starting a podcast in 2025, the overwhelming popularity of true crime podcasts, exploring audience insights and trends, and of course stats! Mean and median numbers!

In this episode, three HPNA Diversity, Equity, Inclusion, & Belonging (DEIB) Committee members reflect on their lived experience- how positionality impacts the way they show up to their work as hospice and palliative care clinicians and researchers and how they've shifted from cultural competency toward cultural responsiveness. Together, these experts discuss how our knowledge and actions must evolve in the face of new information, and how we can foster a healthcare environment that not only acknowledges but celebrates individual identity and culture. Whether you're a clinician, researcher, or anyone passionate about making healthcare more equitable, this conversation provides valuable insight into how we can all "do better" by truly seeing each person as they are.   Nancy Dias, PhD, RN, MSN, FPCN® Nancy Dias is an Associate Professor in the Nurse Science Department at the College of Nursing. Her work experience in nursing includes both experiences in the United States and internationally (India and Oman) as a clinician, educator, administrator, and a researcher. She completed her PhD at Duke University School of Nursing and a 1-year T32 post-doctoral fellowship from Indiana University School of Nursing. As a researcher, she has a niche for a very significant and innovative aspect of pediatric palliative care services that includes caregiver health outcomes, their bereavement processes, social and structural determinants of health, and innovative technology. Her academic initiatives have focused on transforming educational curriculum to integrate a nursing curriculum with a goal “charting a path to achieve health equity”. Her entrepreneurial skills are exemplified through her role as a co-founder of the Indo-American Evidence based practice Academy and development of an innovative app for bereaved families. She has received several research grants and among many awards, she is the recipient of the Research Nurse of the Year Award 2020, from North Carolina Nurses Association. She has also been recognized with several other awards including, East Carolina University College of Nursing Outstanding Faculty award (2022), Outstanding Mentor award from Sigma Theta Tau's Beta Nu chapter (2024). She was inducted as the Fellow in Palliative Care Nursing in 2024. She has international collaborations with nurses in India and Egypt and mentors these nurse scientists with whom she shares common research and scholarship interest. She has several publications and presentations done locally, nationally, and internationally.  Adrienne Jones-Adamczyk, MBE, RN, ACNP-BC ACHPN®, HEC-C Adrienne Jones-Adamczyk MSN, MBE, RN, ACNP-BC, ACHPN®, HEC-C is a Senior Clinical Ethics Specialty Program Director for Banner Health. She has more than 14 years of experience as a board-certified Acute Care Nurse Practitioner and is an Advanced Certified Hospice and Palliative Care Nurse. She has spent her career in Neuroscience, Palliative Medicine, Home Hospice, and Hospice GIP settings. The clinical conundrums and ethical dilemmas of the COVID-19 pandemic inspired her to continue her education in bioethics, and she obtained a Master of Bioethics degree in May 2023 from Harvard Medical School. She continues her work in equity and human flourishing as an active member of the HPNA Diversity, Equity, Inclusion, and Belonging Committee. Katherine Doyon, PhD, MED, RN, CHPN® Kate Doyon is an assistant professor at Boise State University, School of Nursing. She serves on HPNA's Diversity, Equity, Inclusion, and Belonging Committee and Research Advisory Committee and is a former co-chair of the Emerging Scholars Special Interest Group. She is a certified hospice and palliative care nurse and volunteers on the CHPN® Credentialing Committee. She is a member of the most recent Cambia Sojourns Leadership scholars' program. Kate is passionate about mentoring the next generation of hospice and palliative care nurse scientists and mentors several nurse scholars. She is the recipient of the HPNF Research Scholar Award, the first author of the section on health equity for the HPNA Research Agenda and a reviewer for palliative care journals and conferences including the Annual Assembly of Hospice and Palliative Medicine. Through her advocacy, mentorship, and research of equitable hospice and palliative care, Dr. Doyon exemplifies the highest standards of HPNA's commitment to compassionate care.   

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Laura Alder, MD The recent approval of antibody drug conjugates (ADCs) has the potential to address unmet needs associated with second-line treatment options for non-small cell lung cancer, like limited benefits and substantial toxicity. But given the complex structure of ADCs, it's important to identify biomarkers that can predict a patient's response to therapy. That's why the phase 1b TROPION-LUNG02 trial examined the effectiveness of Dato-DXd and HER3-DXd in the presence of predictive biomarkers. Joining Dr. Charles Turck to discuss the trial's findings and implications is Dr. Laura Alder, Assistant Professor of Medicine at Duke University School of Medicine in Durham, North Carolina.

This recording features audio versions of January 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Effectiveness of Track Cauterization in Reduction of Adverse Events for Lung Microwave Ablation ReadSelective Lymphatic Duct Embolization for Treatment of Thoracic Lymphatic Flow Disorders in Children: Technical Aspects and Comparison with Thoracic Duct Embolization ReadA Comparison of Postprocedural Hemoglobin in Catheter-Directed Thrombolysis versus Large-Bore Aspiration Thrombectomy for Acute Pulmonary Embolism ReadClinical Outcomes following Invasive Treatment of Femoropopliteal Artery Disease: A Retrospective Single-Center Cohort Study ReadOutcomes of Endovascular Treatment for Infectious Thoracic Aortic Diseases ReadThe Influence of Preablation Embolization Particle Size on the Size of the Microwave Ablation Zone in a Porcine Orthotopic Renal Tumor Model ReadJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com.  Host:Manbir Singh Sandhu, University of California Riverside School of MedicineAudio editor:Manbir Singh Sandhu, University of California Riverside School of MedicineOutreach coordinator:Millennie Chen, University of California Riverside School of MedicineAbstract readers:Maximillion Hayama, Duke University School of MedicineSonya Choe, University of California Riverside School of MedicineSiddak Dhaliwal, University of Missouri School of MedicineAkumbir Singh Grewal, St. George's University School of MedicineBryan Torres, University of California Riverside School of MedicineJason Hoang, The Ohio State College of MedicineSIR thanks BD for its generous support of the Kinked Wire.Contact us with your ideas and questions, or read more about about interventional radiology in IR Quarterly magazine or SIR's Patient Center.(c) Society of Interventional Radiology.Support the show

Tom Bodrovics welcomes back former congressman Dr. Ron Paul from Texas and Liberty Report host to discuss the link between liberty and the economy. Dr. Paul insists that freer societies are more prosperous, advocating for a sound monetary policy as crucial for economic health. He condemns interventionist policies and criticizes the Federal Reserve's manipulation of interest rates, citing 1921 as evidence of a hands-off approach leading to a better recovery from an economic downturn. During the conversation, Dr. Paul expresses his aspiration to terminate the Federal Reserve and proposes steps towards accomplishing this goal, including repealing the Federal Reserve Act and enforcing the Constitution. Although he acknowledges that the process might not be easy due to the nation's addiction to low-interest rates and easy money, he emphasizes the importance of recognizing inflation as a tax on people's money and advocates for Fed auditing as a path to transparency. Dr. Paul supports gold-backed bonds as a means of promoting fiscal restraint and offering individuals a valuable savings opportunity. He denounces tariffs as an ill-conceived solution for economic matters, suggesting instead the elimination of burdensome business regulations. Furthermore, Dr. Paul expresses concerns about government information's lack of transparency and encourages citizens to educate themselves on constitutional principles in order to safeguard individual liberties. Dr. Paul concludes by urging listeners to act upon their convictions and principles, underlining the significance of education in history and economics. He also presents his homeschooling curriculum as a substantial contribution to fostering individual liberty and countering excessive government control over education and healthcare. Ultimately, Dr. Paul underscores the importance of personal accountability and the risks of government intervention in diverse areas. Time Stamp References:0:00 - Introduction0:36 - Economics of Liberty3:24 - Government Efficiency5:00 - Audit & End The Fed12:58 - Shelton & Gold Bonds14:36 - Tariffs & Regulations23:12 - Accurate Information?25:36 - What Should We Do?27:29 - Wrap Up Guest LinksTwitter: https://x.com/ronpaulWebsite: http://www.ronpaullibertyreport.com/Website: http:///ronpaulinstitute.org Ron Paul is an American author, physician, and former politician. He was the U.S. Representative for Texas' 14th and 22nd congressional districts. Ron represented the 22nd congressional district from 1976 to 1977 and from 1979 to 1985 and then represented the 14th congressional district, which included Galveston, from 1997 to 2013. On three occasions, he sought the United States presidency: as the Libertarian Party nominee in 1988 and as a candidate in the Republican primaries of 2008 and 2012. Paul is a critic of the federal government's fiscal policies, especially the Federal Reserve and the tax policy, as well as the military-industrial complex and the War on Drugs. Paul has also been a vocal critic of mass surveillance policies such as the USA PATRIOT Act and the NSA surveillance programs. Paul was the first chairman of the conservative PAC Citizens for a Sound Economy and has been characterized as the "intellectual godfather" of the Tea Party movement. A native of the Pittsburgh suburb of Green Tree, Pennsylvania, Paul is a graduate of Gettysburg College and the Duke University School of Medicine, where he earned his medical degree. He served as a flight surgeon in the U.S. Air Force from 1963 to 1968. In addition, Ron worked as an obstetrician-gynecologist from the 1960s to the 1980s. He became the first Representative in history to serve concurrently with a son or daughter in the Senate when his son, Rand Paul, was elected to the U.S. Senate from Kentucky in 2010. Paul is a Senior Fellow of the Mises Institute and has been an active writer, publishing on the topics of political and economic theory and publicizing the ideas of econ...

Seasons greetings, nerds! Welcome to episode 147 of Up Yours with More! Merry MODOK and Jolly Ol' BC have returned for another rundown of ridiculousness. As usual, they've got comic book and pop culture headlines, the top 10 books from last week, and books they're excited for this week! News DC's First Superman Poster Flies Online, Trailer Confirmed for This Week Public Domain Day 2025 | Duke University School of Law Warner Bros. Has Dated Dynamic Duo For 2028 And Clayface for 2026 BOOM! Goes to PRH McFarlane Toys Debuts Batman Detective Comics #27 1st App. Statue  The Witcher 4 teaser confirms what happened to Geralt after The Wild Hunt - News - GAMINGbible   Witcher 4 Trailer  Mario Kart 9 Leak Reveals Release Date Surprise ICV2 Showbiz Round-Up Find Us Online at the Following Outlets  Website :: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠upupandawaycomics.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  YouTube :: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@upupawaycomics⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook ::  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/upupawa⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠y and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/uuablueash⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Instagram :: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/upupawaycomics⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Twitter :: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠twitter.com/upupawaycomics⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

NFTs – or non-fungible tokens – have taken the digital world by storm – or perhaps just a downloadable picture of a storm – promising to revolutionize not only the way we perceive, protect, purchase, and own digital assets, but how we might even buy a house or other assets in the real world.  These unique digital certificates, recorded on a blockchain, exploded onto the scene in post-pandemic 2021 with record-breaking sales and widespread media coverage. One of the most amazing examples is "The Merge" by the anonymous artist Pak, which sold for a staggering $91.8 million. The Bored Ape Yacht Club is another fascinating story. This collection of 10,000 unique, cartoonish apes, each with its own distinct features, became incredibly popular in 2021. Owning a Bored Ape would become a status symbol in the NFT community.However, the meteoric rise of NFTs was followed by a significant downturn, leading many to question the future of NFTs. While the initial hype and astronomical prices may have subsided, the underlying technology and potential of NFTs remain promising.For insights into this evolving landscape, listen to my conversation with Cameron Pick of Marshall Gerstein. An experienced expert in intellectual property law with a focus on emerging technologies, Cameron advises clients on a range of legal issues related to NFTs, blockchain, and cryptocurrency. He holds a J.D. from Duke University School of Law and a B.S. with honors in electrical engineering from the University of Illinois, Urbana-Champaign.This podcast is the audio companion to the Journal on Emerging Issues in Litigation. The Journal is a collaborative project between HB Litigation Conferences and the Fastcase legal research family, which includes Full Court Press, Law Street Media, and Docket Alarm. The podcast itself is a joint effort between HB and our friends at Law Street Media. If you have comments or wish to participate in one our projects please drop me a note at Editor@LitigationConferences.com.Tom HagyLitigation Enthusiast andHost of the Emerging Litigation PodcastHome PageLinkedIn

Are you sleeping okay? GIRL. Getting that quality sleep shouldn't be at the bottom of your list! In today's episode, we're talking about how sleep impacts your mental health, skin, hormones, and why we really need to rethink our rest, especially as the year winds down. We're also diving into sleep during pregnancy and postpartum, plus spilling the tea on beauty sleep! Oh, and if you're a coffee girlie—don't worry, we've got tips for you too if you're looking for better sleep. We've got Dr. Jade Wu, a board-certified sleep psychologist and author of Hello Sleep, here to share all the insights. Trust me, you won't want to miss this one. Grab your headphones, let's get into it! LISTEN UP! The Flourish Heights Podcast was made for women, by women. To be empowered in health starts with a true connection with your body. Join Valerie Agyeman, Women's Health Dietitian as she breaks through topics surrounding periods, women's nutrition, body awareness, and self-care.  About Dr. Jade Wu Dr. Jade Wu is a board-certified sleep psychologist specializing in adult insomnia and sleep problems during pregnancy and the postpartum period. She completed her PhD at Boston University and her behavioral medicine residency/fellowship at Duke University School of Medicine. She regularly appears in print media as well as on radio/TV programs such as NPR and ABC News to share sleep health insights with the public. Dr. Wu is the author of Hello Sleep: The Science and Art of Overcoming Insomnia Without Medications. In the clinic, she uses evidence-based methods and a collaborative approach to help people restore sleep health. At home, she loves to nap and play with her kids, in that order.  Connect with Dr. Jade Wu: IG: @dr_jade_wu Stay Connected: Is there a topic you'd like covered on the podcast? Submit it to hello@flourishheights.com Subscribe to our quarterly newsletters: Flourish Heights Newsletter Visit our website + nutrition blog: www.flourishheights.com Follow us on social media: Instagram: @flourishheights / Women's Health Hub: @flourishvulva Facebook: @flourishheights Twitter: @flourishheights Want to support this podcast? Leave a rating, write a review and share! Thank you!

This recording features audio versions of October 2024 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Outcomes Analysis of Yttrium-90 Radioembolization for Tumors Other Than Metastatic Colorectal Cancer from the Radiation-Emitting SIR-Spheres in Nonresectable (RESiN) Registry ReadOpen access: Using Voxel-Based Dosimetry to Evaluate Sphere Concentration and Tumor Dose in Hepatocellular Carcinoma Treated with Yttrium-90 Radiation Segmentectomy with Glass Microspheres ReadClinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic Cholangiocarcinoma ReadComparison of Small-Sized (70–150 μm) and Intermediate-Sized (100–300 μm) Drug-Eluting Embolics for Transarterial Chemoembolization of Small Hepatocellular Carcinomas (≤3 cm) ReadOpen access: Technical Feasibility and Outcome of Cryoablation of Aneurysmal Bone Cysts in Pediatric Patients ReadPrimary Limb-Based Patency for Chronic Limb-Threatening Ischemia Treated with Endovascular Therapy Based on the Global Limb Anatomic Staging System ReadOpen access: Initial Outcomes of Embolization for Type II Endoleak: Comparison of n-Butyl Cyanoacrylate–Ethiodized Oil Mixture with n-Butyl Cyanoacrylate– Ethiodized Oil–Ethanol Mixture ReadTrack Sealing in CT-Guided Lung Biopsy Using Gelatin Sponge Slurry versus Saline in Reducing Postbiopsy Pneumothorax: A Prospective Randomized Study ReadJVIR and SIR thank all those who helped record this episode:Host:Manbir Singh Sandhu, University of California Riverside School of MedicineAudio editor:Hannah Curtis, Loma Linda University School of MedicineAbstract readers:Maximillion Hayama, Duke University School of MedicineLana Kamel, University of Minnesota Medical SchoolJessalyn Yam, University of Illinois College of Medicine at ChicagoSiddak Dhaliwal, University of Missouri School of MedicineJason Hoang, The Ohio State University College of MedicineAkumbir Singh Grewal, St. George University School of MedicineMillennie Chen, University of California Riverside School of MedicineDaniel Roh, Loma Linda University School of Medicine Support the showSupport the show

Donald Beers, Office of Chief Counsel of the Food and Drug Administration (FDA) (retired)Alfred B. EngelbergAbbe Gluck, Yale Law SchoolArti Rai, Duke University School of LawAmeet Sarpatwari, Harvard Medical SchoolMichael Weinberg, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)

From the January 6th attack on the Capitol to recent assassination attempts on former President Donald Trump, political violence and intimidation pose a growing threat to our democracy. Taonga Leslie brings an excerpt from a recent ACS program co-hosted by Giffords Law Center and March for Our Lives featuring a discussion among advocates and legal scholars on the causes of rising political violence, the stakes of the 2024 election, and how progressives can support positive change.Join the Progressive Legal Movement Today: ACSLaw.orgHost: Taonga Leslie, Director of Policy and Program for Racial JusticeGuest: Joseph Blocher, Lanty L. Smith '67 Distinguished Professor of Law, Duke University School of LawGuest: Makennan McBryde, Legal Project Manager, Giffords Law CenterGuest: Mary McCord, Executive Director, Institute for Constitutional Advocacy and Protection, Georgetown University Law CenterGuest: Yvin Shin, Legal Associate, March for Our LivesLink: "Guided By History: Protecting the Public Sphere From Weapons Threats Under Bruen," by Joseph Blocher and Reva Siegel Link: Become a Poll WorkerLink: Election Protection Sign-UpLink: Election Official Legal Defense Network Sign-UpVisit the Podcast Website: Broken Law PodcastEmail the Show: Podcast@ACSLaw.orgFollow ACS on Social Media: Facebook | Instagram | Twitter | LinkedIn | YouTube-----------------Broken Law: About the law, who it serves, and who it doesn't.----------------- Production House: Flint Stone Media Copyright of American Constitution Society 2024.

Judge Roy Altman joins Sarah and David at Duke University School of Law. Note: The opinions expressed on this podcast do not represent Duke (who would have thought that anyways?). The trio discuss Altman's trip to Israel and legal troubles the country has in defending itself. The Agenda: —The intersection of law and military operations —Proportionality as legal principle in armed conflict —How Hamas' tactics complicate the legal landscape of military operations —Tire chalking! And Fourth Amendment issues —Don't erase David's identity, SarahShow notes: —Judge Roy Altman's first appearance on AO —NYU Law Review article on tire chalking —Advisory Opinions live at UNC Advisory Opinions is a production of The Dispatch, a digital media company covering politics, policy, and culture from a non-partisan, conservative perspective. To access all of The Dispatch's offerings—including Sarah's Collision newsletter, weekly livestreams, and other members-only content—click here. Learn more about your ad choices. Visit megaphone.fm/adchoices

Michael Frakes, Duke University School of LawEmily Marden, Sidley Austin LLPNicholson Price, The University of Michigan Law SchoolS. Sean Tu, West Virginia University College of LawMelissa Wasserman, The University of Texas School of LawBruce Wexler, Paul Hastings LLP (moderator)

Today, Hunter is joined by two people who's work attempts to bring people together to heal after a wrongful conviction. Jennifer Thompson, Founder of Healing Justice, and Professor Jamie Lau from Duke University join the show to discuss how they help the wrongfully convicted, the victims in a wrongful conviction, the families of both, and the communities they are from come together to talk and hopefully heal from the bomb that is a wrongful conviction   Guests: Jennifer Thompson, Founder, Healing Justice Jamie Lau, Clinical Professor of Law, Duke University School of Law     Resources: Healing Justice Website https://healingjusticeproject.org/ Contact Jamie https://law.duke.edu/fac/lau https://x.com/laudurham Innocence Network https://innocencenetwork.org/     Contact Hunter Parnell:                                 Publicdefenseless@gmail.com  Instagram @PublicDefenselessPodcast Twitter                                                                 @PDefenselessPod www.publicdefenseless.com  Subscribe to the Patron www.patreon.com/PublicDefenselessPodcast  Donate on PayPal https://www.paypal.com/donate/?hosted_button_id=5KW7WMJWEXTAJ Donate on Stripe https://donate.stripe.com/7sI01tb2v3dwaM8cMN Trying to find a specific part of an episode? Use this link to search transcripts of every episode of the show! https://app.reduct.video/o/eca54fbf9f/p/d543070e6a/share/c34e85194394723d4131/home  

When we wrote our book, ADHD Is Awesome, one of the areas we wanted to cover more was the under-diagnosis of ADHD amongst minority populations. White children get diagnosed with ADHD at a rate of 11.5% while Black children get diagnosed at a rate of 8.9%. Additionally, studies have shown that Black children with symptoms of ADHD are treated more negatively by teachers and other adults. This week, we talk to Dr. Damon Tweedy, a professor of psychiatry at Duke University School of Medicine (and our friend) to learn more.Dr. Tweedy is the author of two books, Black Man in a White Coat: A Doctor's Reflections on Race and Medicine and Facing the Unseen: The Struggle to Center Mental Health in Medicine. His first book made the New York Times bestseller list and was selected by TIME Magazine as a top non-fiction book that year. Dr. Tweedy has been featured in publications including the New York Times, Washington Post, Chicago Tribune, and Discover Magazine. We discuss Dr. Tweedy's personal stories about probably having ADHD himself along with the complicated issue of what it means to be Black and have ADHD. You can learn more about Dr. Tweedy here: https://www.damontweedy.com/.Limited Time Offer! October is ADHD Awareness Month - Get any of our ADHD merchandise for 20% off using code ADHD20: https://holdernessfamilyshop.com/Join Our Webinars! 10/1 - Free webinar with ADDitude Magazine and 10/9 - Pearson Assessments - get 50% off with code HOLDERNESS50.Get our game Family FaceoffGet our game What The FlockJoin Our NewsletterFollow us on YouTubeFollow us on InstagramFollow us on TikTok Follow us on FacebookKim and Penn are award-winning content creators known for their online videos, including original music, song parodies, and comedy sketches. Their videos have resulted in over 2 billion views and 9 million followers across their social media platforms since they (accidentally) went viral in 2013. They have a New York Times bestselling book on ADHD, best-selling book on marriage communication, a top-rated podcast, a fun-filled family card game, and most recently, they were the winners on Season 33 of The Amazing Race.The Holderness Family Podcast is produced by Ann Marie Taepke and edited and engineered by Max Trujillo of Trujillo Media and Sam Allen. Hosted on Acast. See acast.com/privacy for more information.

“The reality is that we are responsible for creating a culture of safety together for everybody in the clinical area. We have to think not only about ourselves and our personal risk, but how exposure to these hazardous drugs persists in the work environment for everybody. And we have to be part of the solution for everybody, even if it's not something that we're personally really worried about being exposed to,” AnnMarie Walton, PhD, MPH, RN, OCN®, CHES, FAAN, associate professor at Duke University School of Nursing in Durham, NC, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about updates to the fourth edition of Safe Handling of Hazardous Drugs, one of ONS's book publications. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 20, 2026. AnnMarie Walton serves in a compensated consultant role with Splashblocker LLC and as a compensated speaker for BD. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to safe handling of hazardous drugs.  Episode Notes Complete this evaluation for free NCPD.  Oncology Nursing Podcast™ episodes: Episode 325: What Changed in the 2024 ASCO/ONS Antineoplastic Administration Safety Standards Episode 308: Hazardous Drugs and Hazardous Waste: Personal, Patient, and Environmental Safety ONS Voice articles: Hazardous Drug Surface Contamination Prevails, Despite More Diligent PPE Strategies to Promote Safe Medication Administration Practices ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: ONS/ONCC Chemotherapy Immunotherapy Certificate™ Safe Handling Basics Clinical Journal of Oncology Nursing articles: Environmental Risk Factors: The Role of Oncology Nurses in Assessing and Reducing the Risk for Exposure Oral Chemotherapy: A Home Safety Educational Framework for Healthcare Providers, Patients, and Caregivers Oral Chemotherapy: An Evidence-Based Practice Change for Safe Handling of Patient Waste Personal Protective Equipment Use and Surface Contamination With Antineoplastic Drugs: The Impact of the COVID-19 Pandemic Oncology Nursing Forum articles: Factors Influencing Nurses' Use of Hazardous Drug Safe Handling Precautions Randomized Controlled Trial of an Intervention to Improve Nurses' Hazardous Drug Handling ONS Learning Library: Safe Handling of Hazardous Drugs Joint ONS and Hematology/Oncology Pharmacy Association position statement: Ensuring Healthcare Worker Safety When Handling Hazardous Drugs ONS Voice video: Hazardous Drug Surface Contamination—The Science Behind the Study To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an Oncology Nursing Podcast™ Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “We know that this book is used in practice sites across the country and increasingly around the world, and we have the privilege of answering lots of questions of ONS's members routinely. And we've also been part of writing guidance documents for ONS. And so, we utilized, as well, some of those questions that have come to us, and we know what people want to know more about. So we've made sure that we've developed a book that would be the most helpful in clinical practice settings.” TS 2:42 “We ensured that the book was in alignment with all of the most recent organizational position statements, standards, and recommendations. And there have been some big ones between the publication of the third and fourth book. So USP 800 is one that everyone knows about, and that became enforceable in November of 2023. … The ONS/HOPA [Hematology/Oncology Pharmacy Association] position statement, which was most recently updated in 2022, was also folded into this book. NIOSH [National Institute for Occupational Safety and Health] came out with two new guidance documents in 2023, and I had the opportunity to serve as a reviewer on one and a contributor to the other. Those two NIOSH guidelines have been folded into this book And then the ONS Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice, which MiKaela Olsen was a lead editor on and I was an author for, have also been folded into this text.” TS 7:01 “We've understood the NIOSH hierarchy of controls for years, and if we look at that hierarchy, it tells us that PPE is important but also the least effective when it comes to controlling exposure. And what's slightly more effective is administrative controls, which are things like changes in our practices, more education, and training. And then even more powerful than administrative controls are engineering controls, and these are your closed-system transfer devices, for example, that are really important in minimizing exposure.” TS 10:31 “[Toilet pluming] is a place that I, for better or worse, spend a lot of time. And I have a colleague, Tom Connor from NIH [National Institutes of Health], who likes to joke when people ask him about his work. He says, ‘Oh, it's in the toilet.' And so I'm going to steal that from him and say a lot of my research is in the toilet, too.” TS 13:16 “I feel like people don't know how contaminated toilets are and how contaminated floors are. And I've already told you my tip about leaving your work shoes outside. But I think if people were more aware that the toilets and the floors are often the most contaminated places on a unit, there would be more attention paid to people who are coming into contact with those surfaces and bear a lot of the exposure risk.” TS 22:51

In this episode, Dr. Harry Severance, Adjunct Assistant Professor in the Department of Medicine, Duke University School of Medicine, joins the Becker's Healthcare Podcast to discuss the increasingly toxic work environments in healthcare. He shares insights on how disruptive workplaces, management practices, and physician shortages threaten the future of healthcare, urging a collaborative approach to solving these systemic issues.

The number of Americans using both cannabis and tobacco is increasing, with a particular surge among older adults, a new study finds. Researchers at Duke University School of Medicine who analyzed two decades of national data warn that the combination poses greater health risks than the dangers of using either substance alone. In 2021, 6.38% of U.S. adults reported using both cannabis and tobacco within the past month. While this might seem like a relatively small percentage, it's a big jump from previous years. Researchers attribute the trend to more states legalizing marijuana, and people becoming more accepting of and comfortable with cannabis. When looking at the 2021 data, younger individuals, people with lower educational attainment and residing in a state with a medical marijuana law, were most likely to report co-use,” said lead study author Dana Rubenstein, a fourth-year medical student at the Duke University School of Medicine and translational science researcher. Trends in cannabis and tobacco co-use prevalence have not been examined in many years while regulatory policy has been changing quite a bit. Cannabis Talk 101, “The World's #1 Source For Everything Cannabis”, made global history by becoming the first cannabis show to partner with iHeartMedia, on 4/20/2020. Thank you for listening & watching Cannabis Talk 101 with Christopher Wright, aka "Blue" the CEO and creator of Cannabis Talk 101 and the Cannabis Talk Network. & Joe Grande, former Co-Host on Big Boy's Neighborhood on Power 106 FM, On-Air with Ryan Seacrest on 102.7 KIIS FM in Los Angeles and The Dog House in the Bay Area on WILD 94.9 KYLD. FOX SPORTS, NBC SPORTS. Financial Fridays with Tony Kassaei, The Inside Investor, 40 TONS TALK, WITH ANTHONY SLIMBURG, CHRONIC HISTORY WITH HISTORY CONNOR V. Toking with the Stars with Chuckie & Marty, & on YouTube, IHeartRadio App, Spotify, & Apple Podcasts. See omnystudio.com/listener for privacy information.

Mike uses the platforms of business coaching and leadership training to fulfill his passion: helping others maximize their own personal and professional value.   As a member of the 8150 Advisors team, Mike collaborates with private practice owners through strategic growth, creating next level leaders, operational efficiency, and team engagement. Several practices have doubled in practice value as result of their collaboration.  Prior to joining the 8150 team, Mike helped Rock Valley Physical Therapy grow from 26 to 52 locations as their first VP of Growth & Development. New patient volumes increased 210% during his six-year tenure where he was responsible for de novo and mature clinic growth. While serving as Director of Operations for Proaxis Therapy, he was an integral leader in developing physician relations, operational excellence, and a five-star patient experience. Dedicated to life-long learning, Mike earned a BS from Mount Union College, an MDiv with Leadership Specialization from Indiana Wesleyan University, and a DPT from the Duke University School of Medicine. Mike is a Certified Coach and DISC Personality Assessment Trainer through the Maxwell Leadership Team. Mike began his career at the Ohio State University Sports Medicine Center where his experiences included consulting with the US Army Special Forces, treating a Masters champion and several NFL draft picks. He has served APTA and PPS as a Federal Affairs Liaison, APTA Delegate, PPS Impact Editorial Board Member, and PPS Annual Conference presenter. In addition to his business ventures, Mike serves part-time as the Partner Relations Manager for Zoe Empowers.  Zoe is an empowerment-based program in India and nine African countries which transforms youth-led households to self-sufficiency in just three years.  He has led several trips to Rwanda, Kenya, and Malawi to allow US partners to see the program's impact.  Mike lives in Iowa and enjoys time with his wife Kim (also a PT!), their four boys, and two dogs.

Dr. Linton Yee, Associate Dean for Admissions at Duke University School of Medicine joins us to discuss how applicants can earn a spot in this highly competitive program. Dr. Yee walks listeners through the unique curriculum which focuses on integrating basic science and clinical experiences from the first year. In addition to strong academic performance, Duke looks for clinical and research experiences, as well as a vision for the future in medicine. Dr. Yee gives an inside look at what applicants can expect from the MMI interviews.Relevant Links:Duke Med SchoolMed QuizRelated Admissions Straight Talk Episodes:Getting Into Med School Isn't Easy…But This Applicant Did It! Get Accepted to Loyola Stritch Medical School Submit Successful Secondaries for Medical School Case Western Reserve University School of Medicine Follow UsYouTubeFacebookLinkedInContact Uswww.accepted.comsupport@accepted.com+1 (310) 815-9553

In this episode of the Brain & Life podcast, American country music singer Drake White joins co-host Dr. Katy Peters. Drake shares about his singing career and how it has been affected by his journey with a diagnosis of arteriovenous malformation (AVM.) Dr. Peters is then joined by Dr. Ali Zomorodi, Professor of Neurosurgery at Duke University School of Medicine. Dr. Zomorodi explains what an AVM is, what the risk factors and treatment options are, and what the future looks like for patients.   Additional Resources What are arteriovenous malformations? Navigating the Complexities of Stroke Being Thankful for Recovery While Grieving a Former Life   Other Brain & Life Episodes on this Topic Connecting Music and Mind with Singer Renée Fleming Timothy Omundson on Stroke Recovery and His Return to Television Resiliency and Caregiving with Janet Fanaki   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media:   Guests: Drake White @drakewhitestomp; Dr. Ali Zomorodi @dukehealth Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

In this episode, we are joined by a guest co-host, Leah Kehoe, another member of the International Trade team at Dentons! Leah and Milana interview Tim Meyer, a constitutional law professor at Duke University School of Law, on the effects of the US Supreme Court recently overturning the landmark Chevron decision. Professor Meyer explains the concepts of foreign affairs exceptionalism, the Major Questions Doctrine, IEEPA emergency powers, and the expected uncertainties and certainties in the sanctions space that will follow. Stay tuned until the end for Dentons' International Trade associates' summer update.

This recording features audio versions of September 2024 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy ReadImage-Guided Energy Ablation for Palliation of Painful Bony Metastases—A Systematic Review ReadImpact of Percutaneous Cryoablation on Renal Function in Patients with Stage I Renal Cell Carcinoma: A Systematic Review and Meta-Analysis ReadPredictive Factors for Recurrent Hemoptysis after Bronchial Artery Embolization in Patients with Lung Cancer ReadRadiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter Study ReadEffectiveness of Genicular Artery Embolization for Reducing Synovitis as Assessed by Contrast-Enhanced MR Imaging in Knee Osteoarthritis: A Pilot Study ReadHepatobiliary Infection after Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Prior Biliary Intervention: A Multi-Institution Retrospective Study ReadJVIR and SIR thank all those who helped record this episode:Host:Manbir Singh Sandhu, University of California Riverside School of MedicineAudio editor:Sonya Choe, University of California Riverside School of MedicineAbstract readers:Maximillian Hayama, Duke University School of MedicineIsabelle Barbosa, Frank H. Netter MD School of MedicineDaniel Roh, Loma Linda University School of MedicineSiddak Dhaliwal, University of Missouri School of MedicineEric Chang, University of Illinois-Chicago College of MedicineJoy Achuonjei, MD, Northwell HealthMaximillian Denys, University of California Riverside School of MedicineSupport the Show.

Ron Paul is a former, twelve-term, U.S. Congressman who enjoys a national reputation as the premier advocate for liberty in politics today. A two-time presidential candidate, Dr. Paul is a leading spokesman for individual liberty, privacy, limited constitutional government, low taxes and spending, free markets, restrained foreign policy, and sound money based on a commodity-backed currency. He graduated from Gettysburg College and the Duke University School of Medicine, before serving as a flight surgeon in the U.S. Air Force during the 1960s and then as a specialist in obstetrics/gynecology in private medical practice. Dr. Paul is the author of the #1 New York Times bestselling books Revolution: A Manifesto and End the Fed. The New York Post has called him a man who “cannot be bought by special interests. There are few people in public life who, through thick and thin, rain or shine, stick to their principles.”

This week marks the formidable return of Ann Brown, MD, MHS, to the Faculty Factory as she joins us to discuss managing difficult behaviors and navigating awkward and challenging conversations, both professionally and personally. Dr. Brown often coaches faculty on overcoming these situations in her current role as an executive coach. With extensive leadership experience in academic medicine, she is the former Vice Dean for Faculty at Duke University School of Medicine, a position she held for more than 11 years. She emphasizes the importance of recognizing personal emotional triggers and stepping back to understand the context of difficult conversations in today's podcast. According to Dr. Brown, the first step is awareness. By cultivating curiosity rather than judgment, we can “get to a better place” regarding healthier dialogue, collaborative workplace settings, and improved relationships moving forward. Contact, Dr. Brown via email: Annbrowncoaching@outlook.com Learn More:  https://facultyfactory.org/toxic-behavior/ 

In line with the mantra of this show - to "own your health" - this week we speak with gastroenterologist Dr. Supriya Rao, whose Gutsy Girl MD platform has evolved into the go-to resource for all things gut health, nutrition, and lifestyle-related. Supriya is quadruple board certified in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine. She received her undergrad degree from MIT, followed by graduation from Duke University School of Medicine. In addition to her role as managing partner at Integrated Gastroenterology Consultants in 2014, she serves as Director for Medical Weight Loss at Lowell General Hospital. Supriya is passionate about empowering people to improve their health through sustainable lifestyle changes, and enjoys traveling, running, yoga and spending time with family and friends. We touched on numerous topics, including: The pivotal importance of a healthy gut microbiome, and the benefits of practices such as "eating the rainbow." The implications of common phrases like "gut feeling," or "going with our gut" - i.e., an underlying connection between gastrointestinal function and cognition The scientific basis for this linkage with the gut brain axis, and the staggering fact that more than 90% of the body's serotonin is produced in the gut Dr. Rao's Gutsy Girl MD platform, which leverages Blue Zones principles, newer disciplines such as lifestyle medicine, as well as nutrition, relationships, and other harbingers of whole health to provide patients with a comprehensive approach to owning their health via Instagram and other channels. Supriya's somewhat circuitous path to her current specialty of medicine, a bit of a departure from her start in computer science at MIT. The differences between the multi-faceted discipline of gastroenterology, and other more compartmentalized specialties, and why it appealed to Supriya. The double-edged sword of the South Asian diet, which includes both good (i.e., turmeric, cardamom and other Ayurvedic ingredients) and not so good (i.e., simple carbohydrates) The challenges doctors face in adhering to the age-old "physician, heal thyself" mantra A look at "the good, the bad, and the ugly" behind biohacking Want to learn more about all things gut health from Gutsy Girl MD? Connect with Supriya on Instagram at @gutsygirlmd, or visit her at gustygirlmd.com or myigic.com. Connect with Nikhil to learn more about ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Untether Your Life⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and other projects: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Originally published in November 30 2023, in this episode, Dr. Pei Zhou from the Duke University School of Medicine joins the podcast and talks to Luis about LPC-233. This is a compound that shows bactericidal activity against some gram-negative rods. LPC-233 is an LpxC inhibitor. What is LpxC? How does LPC-233 works? What are some challenges of developing LpxC inhibitors? Tune in to find out.Link to article: https://doi.org/10.1126/scitranslmed.adf5668Questions? Feedback? Send those to letstalkmicro@outlook.comWant to support the podcast? Here's how:Venmo: https://venmo.com/u/letstalkmicroBuy me a Ko-fi: https://ko-fi.com/letstalkmicro

This episode will be part celebration, part reflection, and part insight. We will be celebrating what we learned from 1 year of hosting a live radio show and podcast, looking back at some of the highlights, and also sharing specific data on a group coaching program that follows the framework that our seasons have been focusing on this past year: Navigating Uncertainty, Developing Leadership Identity, Mapping a Strategy, Navigating Complexity, and Making a Greater Impact. WHAT YOU WILL LEARN:How do you make an impact on leadership development in a large healthcare system where people generally work in siloes? How can you help clinical and academic leaders feel more prepared and more supported to create organizational change and lead in times of uncertainty? We will review our proprietary research-based 5-stage Strategic Leadership Pathway model and the results from a program evaluation study of this model conducted at Duke University and presented at the Pediatric Academic Societies Meeting.We'll explore questions such as:1. What might be the impetus for starting a group coaching program within academic healthcare - what was the need identified and why group coaching?2. What can you expect to gain from such a program and what are the implications?3. What impact could this kind of program potentially serve in highly complex academic medicine and healthcare environments in supporting leaders in those environments. And we'll also celebrate 50 episodes and 1 year of doing this radio show!***ABOUT OUR GUESTS:Dr. Mara Becker, MD, MSCE, is a physician-scientist and Vice Dean for Faculty of Duke University School of Medicine's Office of Faculty. She oversees the Office for Faculty and provides leadership on all faculty matters including advancement, development, mentoring and professionalism. Her previous translational research focused on identifying factors that enhance response and minimize toxicity to drugs used for the treatment of rheumatic diseases in children, focusing on individualized therapeutic strategies. She previously served as Division Director of Rheumatology and Associate Chair for the Department of Pediatrics at Children's Mercy-Kansas City. Dr. Becker is actively involved in national committees and organizations including the FDA Arthritis Advisory Committee, American College of Rheumatology, American Board of Pediatrics, Rheumatology Research Foundation Board of Directors, and Childhood Arthritis and Rheumatology Research Alliance.Jessica Schonberg, M.Ed. is their Director of Educational Programs for Duke University School of Medicine's Office of Faculty. She directs and oversees their Leadership and Faculty Development and funding programs. Jessica has a Master's degree in Training and Development from North Carolina State University. Jessica Sperling, Ph.D., is and Assistant Professor of Internal Medicine at Duke University, as well as the Director of Applied Research, Evaluation, & Engagement of Duke University's Social Science Research Institute (SSRI). She focuses on responsive and collaborative research, evaluation, and research/practice partnership. At Duke, her work has focused on education, healthcare delivery, diversity/inequality, and innovation/pilot programming. She holds a Ph.D. in Sociology from the Graduate Center of the City University of New York.***IF YOU ENJOYED THIS EPISODE, CAN I ASK A FAVOR?We do not receive any funding or sponsorship for this podcast. If you learned something and feel others could also benefit, please leave a positive review. Every review helps amplify our work and visibility. This is especially helpful for small women-owned boot-strapped businesses. Simply go to the bottom of the Apple Podcast page to enter a review. Thank you!***LINKS MENTIONED IN EPISODE:Guest Website: https://medschool.duke.edu/blog/piloting-leadership-group-coaching-program-pediatric-division-chiefs#sq_hro4iausqfOur website: www.gotowerscope.comhttps://medschool.duke.edu/blog/piloting-leadership-group-coaching-program-pediatric-division-chiefs#sq_hro4iausqf #StrategicLeadershipPathwayModel #LeadershipGroupCoaching #LeadershipDevelopment #TheHardSkills #Healthcare #Academia #Results #Celebrating1YearTune in for this empowering conversation at TalkRadio.nyc

Alexander Rotta, MD is a Professor of Pediatrics and the Division Chief of Pediatric Critical Care at Duke University School of Medicine. He is an accomplished intensivist, educator and physician scientist with well over 100 publications with a focus on respiratory care in critically ill children. He authored a review on high-frequency jet ventilation that served as the foundation for today's episode. Learning Objectives:By the end of this podcast, listeners should be able to discuss:The physiologic rationale supporting the use of high frequency jet ventilation (HFJV).Patient populations most likely to benefit from HFJV.Key published evidence that informs our use of HFJV in pediatric critical care.An expert approach to managing a patient with HFJV.References:Cheifetz IM, Rotta AT. High-Frequency Jet Ventilation in Pediatric Acute Respiratory Failure. Respir Care. 2021 Feb;66(2):191-198. doi: 10.4187/respcare.08241. Epub 2020 Oct 2. PMID: 33008841.Miller AG, Scott BL, Gates RM, Haynes KE, Lopez Domowicz DA, Rotta AT. High-Frequency Jet Ventilation in Infants With Congenital Heart Disease. Respir Care. 2021 Nov;66(11):1684-1690. doi: 10.4187/respcare.09186. Epub 2021 Jun 9. PMID: 34108137.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the Show.How to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

The fix is in! By all metrics, Caitlin Clark is the clear-cut choice for the WNBA Rookie of the Year. Between points scored and assists, Clark leads all players in production, but that doesn't matter. All the league and the media want to talk about is Angel Reese's fraudulent double-double record, and Jason and Jay Skapinac have the proof. Oklahoma State head coach Mike Gundy is taking heat over comments he made following the DUI arrest of Ollie Gordon, his top running back. Is Gundy defending and promoting his behavior, or is the coach guilty of felonious honesty? Whitlock and T.J. Moe debate the Cowboys' coach's conundrum. Joe Biden used the pulpit of a black church to preach his leftist sermon over the weekend. In Tennessee Harmony, Anthony Walker, Virgil Walker, and Kevin Donahue take up the debate of politics and the church. Did you know that being on time is a symbol of white supremacy? It is according to Duke University School of Medicine. Jason destroys this myth in a timely manner in today's Justice for TT. We want to hear from the Fearless Army!! Join the conversation in the show chat, leave a comment or email Jason at FearlessBlazeShow@gmail.com Visit https://TheBlaze.com. Explore the all-new ad-free experience and see for yourself how we're standing up against suppression and prioritizing independent journalism. ​​Today's Sponsors: GOOD RANCHERS Use my code FEARLESS at https://GoodRanchers.com and with your subscription you can claim $100 off plus FREE wagyu burgers for a year while supporting veterans this Independence Day month. It's time to revolt and claim your independence from the grocery store meat aisle. PREBORN Everyday, young, scared women, who don't think they have options, are choosing abortion. Preborn seeks these women out before they make the ultimate choice and introduces them to the life growing inside of them through FREE ultrasounds because of YOU who donate. Help rescue babies' lives and donate by dialing #250 and say the keyword, "BABY." or go to https://Preborn.com/Fearless BALANCE OF NATURE Go to https://balanceofnature.com you'll get 35% off PLUS $10 off any additional sets with your first order as a preferred customer by using my discount code: “FEARLESS”. That's limited to five sets, but you'll save a ton of money while getting the fruits and vegetables you need in your diet! Get 10% off Blaze swag by using code Fearless10 at https://shop.blazemedia.com/fearless Make yourself an official member of the “Fearless Army!” Support Conservative Voices! Subscribe to BlazeTV at https://get.blazetv.com/FEARLESS and get $20 off your yearly subscription. CLICK HERE to Subscribe to Jason Whitlock's YouTube: https://bit.ly/3jFL36G CLICK HERE to Listen to Jason Whitlock's podcast: https://apple.co/3zHaeLT CLICK HERE to Follow Jason Whitlock on Twitter: https://bit.ly/3hvSjiJ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Eben Alexander is the author of the New York Times best-selling book Proof of Heaven, which explores Dr. Alexander's journey into the afterlife during a near-death experience. His account challenges scientific beliefs and offers a compelling argument for the existence of an afterlife. A graduate of the University of North Carolina at Chapel Hill, Dr. Alexander received his medical degree from Duke University School of Medicine in 1980. He taught neurosurgery at Harvard Medical School in Boston for fifteen years, and has performed over 4,000 neurosurgical operations. During his academic career he authored or co-authored over 150 chapters and papers in peer reviewed journals, authored or edited five books on radiosurgery and neurosurgery, and made over 230 presentations at conferences and medical centers around the world. Since his NDE, Dr. Alexander has dedicated himself to sharing information about near-death experiences and other spiritually-transformative experiences, and what they teach us about consciousness and the nature of reality. He continues to promote further research on the unifying elements of science and spirituality, and together with Karen Newell, regularly teaches others ways to tap into our greater mind and the power of the heart to facilitate enhancement of healing, relationships, creativity, guidance, and more. Reality Life with Kate Casey Patreon: http://www.patreon.com/katecasey Twitter: https://twitter.com/katecasey Instagram: http://www.instagram.com/katecaseyca Tik Tok: http://www.tiktok.com/itskatecasey Cameo: https://cameo.com/katecasey Facebook Group: https://www.facebook.com/groups/113157919338245 Amazon.com: www.amazon.com/shop/katecaseySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

CardioNerds (Drs. Gurleen Kaur and Richard Ferraro) and episode FIT Lead Dr. Spencer Carter (Cardiology Fellow at UT Southwestern) discuss the clinical implementation of GLP-1 receptor agonists with Dr. Neha Pagidapati (Faculty at Duke University School of Medicine). In this episode of the CardioNerds Cardiovascular Prevention Series, we discuss the clinical implementation of glucagon-like peptide-1 (GLP-1) receptor agonists. We cover the clinical indications, metabolic and cardiovascular benefits, and potential limitations of these emerging and exciting therapies. Show notes were drafted by Dr. Spencer Carter. Audio editing was performed by CardioNerds Academy Intern, student Dr. Pacey Wetstein. This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Novo Nordisk. See below for continuing medical education credit. Claim CME for this episode HERE. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls and Quotes - Clinical Implementation of GLP-1 Receptor Agonists GLP-1 agonists work through a variety of mechanisms to counteract metabolic disease. They increase insulin secretion, inhibit glucagon secretion, slow gastric motility, and increase satiety to limit excess energy intake. Patients with type II diabetes and an elevated risk for atherosclerotic cardiovascular disease should be considered for GLP-1 agonist therapy regardless of hemoglobin A1c. GLP-1 agonists offer significant ASCVD risk reduction even in the absence of diabetes. Newer data suggest a significant reduction in cardiovascular events with GLP-1 agonist therapy in patients who are overweight or obese and have a prior history of heart disease. GLP-1 agonists should generally be avoided in patients with a history of medullary thyroid cancer or MEN2. As these medications slow gastric emptying, relative contraindications include history of recurrent pancreatitis and gastroparesis. GLP-1 agonists should be initially prescribed at the lowest dose and slowly uptitrated to avoid gastrointestinal side effects. Show notes - Clinical Implementation of GLP-1 Receptor Agonists What were the groundbreaking findings of the STEP1 and SURMOUNT-1 trials and how these impact cardiovascular wellness? The STEP1 and SURMOUNT trials demonstrated sustained clinically relevant reduction in body weight with semaglutide and tripeptide, respectively, in patients with overweight and obesity. As obesity is an important risk factor for the development of cardiovascular disease, weight reduction meaningfully contributes to cardiovascular wellness. What were the findings of the LEADER trial and their implications for patients with type II diabetes and high cardiovascular risk? The LEADER trial demonstrated a significant reduction in the rate of cardiovascular death, nonfatal MI, or nonfatal stroke in patients with type II diabetes treated with liraglutide. GLP-1 receptor agonist therapy should be considered in all patients with type II diabetes and elevated ASCVD risk regardless of A1c or current hyperglycemic therapy. What are current indications for GLP1 agonists in the context of cardiometabolic disease. GLP-1 receptor agonists should be considered in patients with type II diabetes and high ASCVD risk OR patients without diabetes who are overweight/obese and have a history of cardiovascular disease. What are important side effects or contraindications to GLP1 agents when used for cardiovascular risk reduction and wellness? GLP-1 receptor agonists should be avoided in patients with a history of medullary thyroid cancer or MEN2. Relative contraindications include recurrent pancreatitis, gastroparesis,